Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene

Maturitas

Volumn 78, Issue 3, 2014, Pages 212-218

  Abraham, Lucy ^a   Pinkerton, Joann V ^b   Messig, Michael ^c   Ryan, Kelly A ^c   Komm, Barry S ^c   Mirkin, Sebastian ^c  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c PFIZER INC   (United States)

Author keywords

CE BZA; Menopause specific quality of life; Osteoporosis; TSECs; Vasomotor symptoms; Vulvar vaginal atrophy

Indexed keywords

BAZEDOXIFENE PLUS CONJUGATED ESTROGEN; PLACEBO; BAZEDOXIFENE; CONJUGATED ESTROGEN; ESTROGEN; INDOLE DERIVATIVE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADULT; ARTICLE; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MENOPAUSE; MENOPAUSE SPECIFIC QUALITY OF LIFE; MULTICENTER STUDY (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHYSICAL ACTIVITY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEXUAL FUNCTION; SEXUALITY; SOCIAL PSYCHOLOGY; STATISTICAL SIGNIFICANCE; VAGINA ATROPHY; VASOMOTOR DISORDER; VASOMOTOR REFLEX; CONTROLLED STUDY; GENITAL DISEASES, FEMALE; HOT FLASHES; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PATHOLOGY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; VAGINA; VAGINAL DISEASES; VULVA; VULVAR DISEASES;

DOUBLE-BLIND METHOD; ESTROGENS; ESTROGENS, CONJUGATED (USP); FEMALE; GENITAL DISEASES, FEMALE; HOT FLASHES; HUMANS; INDOLES; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; VAGINA; VAGINAL DISEASES; VULVA; VULVAR DISEASES;

EID: 84902653747     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2014.04.008     Document Type: Article

References (30)

1. G.A. Greendale, N.P. Lee, and E.R. Arriola The menopause Lancet 353 1999 571 580
2. Research on the menopause in the 1990. Report of a WHO Scientific Group World Health Organ Tech Rep Ser 866 1996 1 107
3. E. Anderson, S. Hamburger, J.H. Liu, and R.W. Rebar Characteristics of menopausal women seeking assistance Am J Obstet Gynecol 156 1987 428 433
4. J.R. Hilditch, J. Lewis, and A. Peter et al. A menopause-specific quality of life questionnaire: development and psychometric properties Maturitas 24 1996 161 175
5. S. Mirkin, and J.H. Pickar Management of osteoporosis and menopausal symptoms: focus on bazedoxifene/conjugated estrogen combination Int J Women's Health 5 2013 465 475
6. J.V. Pinkerton, W.H. Utian, G.D. Constantine, S. Olivier, and J.H. Pickar Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial Menopause 16 2009 1116 1124
7. R. Kagan, R.S. Williams, K. Pan, S. Mirkin, and J.H. Pickar A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women Menopause 17 2010 281 289
8. J.V. Pinkerton, K. Pan, and L. Abraham et al. Sleep parameters and health-related quality of life with bazedoxifene/conjugated estrogens: a randomized trial Menopause 21 2014 252 259
9. R. Lindsay, J.C. Gallagher, R. Kagan, J.H. Pickar, and G. Constantine Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women Fertil Steril 92 2009 1045 1052
10. J.V. Pinkerton, J.A. Harvey, and K. Pan et al. Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial Obstet Gynecol 121 2013 959 968
11. J.H. Pickar, I.T. Yeh, G. Bachmann, and L. Speroff Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy Fertil Steril 92 2009 1018 1024
12. R.A. Lobo, J.V. Pinkerton, and M.L. Gass et al. Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile Fertil Steril 92 2009 1025 1038
13. J.V. Pinkerton, H. Taylor, K. Pan, and A. Chines Breast parameters with bazedoxifene/conjugated estrogens in randomized, controlled trials of postmenopausal women Menopause 17 2010 1221 1222 [abstract]
14. W. Utian, H. Yu, J. Bobula, S. Mirkin, S. Olivier, and J.H. Pickar Bazedoxifene/conjugated estrogens and quality of life in postmenopausal women Maturitas 63 2009 329 335
15. G. Bachmann, J. Bobula, and S. Mirkin Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy Climacteric 13 2010 132 140
16. S. Mirkin, B.S. Komm, K. Pan, and A.A. Chines Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women Climacteric 16 2013 338 346
17. J.V. Pinkerton, J.A. Harvey, and R. Lindsay et al. Effects of bazedoxifene/conjugated estrogens on the endometrium and bone: a randomized trial J Clin Endocrinol Metab 99 2014 E189 E198
18. J.E. Lewis, J.R. Hilditch, and C.J. Wong Further psychometric property development of the Menopause-Specific Quality of Life questionnaire and development of a modified version, MENQOL-Intervention questionnaire Maturitas 50 2005 209 221
19. A.G. Bushmakin, L. Abraham, J.V. Pinkerton, J.C. Cappelleri, and S. Mirkin Confirmatory factor analysis and evaluation of clinically important differences in menopause-specific quality of life associated with bazedoxifene/conjugated estrogens Menopause 2013 [Epub ahead of print]
20. L. Abraham, A.G. Bushmakin, J.V. Pinkerton, J.C. Cappelleri, and S. Mirkin Confirmatory factor analysis and evaluation of clinically important differences in menopause-specific quality of life associated with bazedoxifene/conjugated estrogens in a vulvar/vaginal atrophy population Value Health 16 2013 A337 [abstract]
21. J.C. Cappelleri, K.H. Zou, A.G. Bushmakin, J.M.J. Alvir, D. Alemayehu, and T. Symonds Patient-reported outcomes. measurement, implementation and interpretation 2014 CRC Press Boca Raton, FL
22. H. Savolainen-Peltonen, H. Hautamaki, P. Tuomikoski, O. Ylikorkala, and T.S. Mikkola Health-related quality of life in women with or without hot flashes: a randomized placebo-controlled trial with hormone therapy Menopause 2013 [Epub ahead of print]
23. W.H. Utian, and N.F. Woods Impact of hormone therapy on quality of life after menopause Menopause 20 2013 1098 1105
24. J. Hays, J.K. Ockene, and R.L. Brunner et al. Effects of estrogen plus progestin on health-related quality of life N Engl J Med 348 2003 1839 1854
25. R.L. Brunner, M. Gass, and A. Aragaki et al. Effects of conjugated equine estrogen on health-related quality of life in postmenopausal women with hysterectomy: results from the Women's Health Initiative Randomized Clinical Trial Arch Intern Med 165 2005 1976 1986
26. M.A. Hlatky, D. Boothroyd, E. Vittinghoff, P. Sharp, and M.A. Whooley Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy: results from the Heart and Estrogen/Progestin Replacement Study (HERS) trial JAMA 287 2002 591 597
27. S.D. Harlow, M. Gass, and J.E. Hall et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging Menopause 19 2012 387 395
28. J.V. Pinkerton, L. Abraham, and A.G. Bushmakin et al. Evaluation of the efficacy and safety of bazedoxifene/conjugated estrogens for secondary outcomes including vasomotor symptoms in postmenopausal women by years since menopause in the Selective Estrogens, Menopause and Response to Therapy (SMART) trials J Womens Health (Larchmt) 23 2014 18 28
29. J.V. Pinkerton, A.G. Bushmakin, J. Racketa, J.C. Cappelleri, A.A. Chines, and S. Mirkin Evaluation of the direct and indirect effects of bazedoxifene/conjugated estrogens on sleep disturbance using mediation modeling Menopause 21 2014 243 251
30. C.D. Hill, S.E. Fehnel, J.D. Bobula, H. Yu, and L.D. McLeod Development and preliminary validation of the Menopause Symptoms Treatment Satisfaction Questionnaire (MS-TSQ) Menopause 14 2007 1047 1055